Synergy Pharmaceuticals (FRA:S90) Scaled Net Operating Assets : -0.23 (As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Synergy Pharmaceuticals's operating assets for the quarter that ended in Sep. 2018 was €32.05 Mil. Synergy Pharmaceuticals's operating liabilities for the quarter that ended in Sep. 2018 was €51.17 Mil. Synergy Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2018 was €82.69 Mil. Therefore, Synergy Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2018 was -0.23.

Synergy Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Synergy Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Scaled Net Operating Assets Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.33

-0.21

-0.09

-0.20

-0.26

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.06	-0.18	-0.12	-0.06	-0.23

Competitive Comparison of Synergy Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Scaled Net Operating Assets falls into.

Synergy Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Synergy Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2017 )
=	(Operating Assets (A: Dec. 2017 )	-	Operating Liabilities (A: Dec. 2017 ))	/	Total Assets (A: Dec. 2016 )
=	(25.029	-	47.457)	/	85.18
=	-0.26

where

	Operating Assets		(A: Dec. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	140.782	-	115.753
=	25.029

	Operating Liabilities		(A: Dec. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	145.445	-	97.988	-	0
=	47.457

Synergy Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2018 )
=	(Operating Assets (Q: Sep. 2018 )	-	Operating Liabilities (Q: Sep. 2018 ))	/	Total Assets (Q: Jun. 2018 )
=	(32.045	-	51.172)	/	82.694
=	-0.23

where

	Operating Assets		(Q: Sep. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	71.164	-	39.119
=	32.045

	Operating Liabilities		(Q: Sep. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	153.646	-	0	-	102.474
=	51.172

Synergy Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines